我国专利制度变迁对企业技术战略的影响——以外资制药企业为例  

Effects of China's patent regime reform on firms' technology strategy——the case of foreign pharmaceutical firms

作　　者：何习[1] 陈向东[1] 

机构地区：[1]北京航空航天大学经济管理学院,北京100191

出　　处：《科学学研究》2012年第11期1641-1649,共9页Studies in Science of Science

基　　金：国家自然科学基金资助项目(70772011)

摘　　要：我国专利法自1985年正式实施以来一共经历了三次变革,其中2000年的专利法改革是为了加入WTO做准备而将有关条款和TRIPs接轨,进一步加大了专利保护的强度,制药业作为典型的技术创新驱动型产业理应对专利制度变迁的反应很敏感。此研究利用中国1995至2005年间的专利数据,在定义企业整体技术范围的基础上,结合统计和计量方法从技术规模和技术范围两个角度研究了此次专利法改革对外资制药企业可能产生的影响。发现此次专利法改革使得中国本土企业的技术范围收敛,技术规模扩大;但是对美国、德国和日本企业的技术范围和技术规模基本没有影响。Since its enforcement in 1985, Patent Law in China has gone through 3 reforms. The reform in 2000 was in preparation for China＇ s entry into WTO and it enhances patent protection. Pharmaceutical industry is supposed to be sensitive to this change because it is driven by technology innovation. Based on Chinese patent data from 1995 to 2005 and the definition of technology scope and technolo- gy size, this paper examines the effects of patent regime reform in 2000 on the technology strategies of foreign pharmaceutical firms in China. Our study reveals that this patent regime reform decreases the technology scope and increases the technology size of firms in Chi- na, however, this reform seems to have no influence on the technology strategies of foreign pharmaceutical firms in China.

关 键 词：专利制度 技术范围 技术规模 

分 类 号：F062.4[经济管理—政治经济学]